+1 408 548 0405
info@indx.ai

iNDX.AI Recognized on Pharma Tech Outlook’s list of Top 10 Analytics Solution Providers – 2020

iNDX.AI Recognized on Pharma Tech Outlook’s list of Top 10 Analytics Solution Providers – 2020 Cupertino, CA, November 30, 2020. Pharma Tech Outlook recognizes iNDX.Ai on its annual list of Top 10 Analytics Solution Providers – 2020. iNDX.Ai develops innovative software application suites combining the innovations in life sciences with the innovations in data sciences…

iNDX.Ai announces 21 CFR part 11 compliance of its flagship product iCore

iNDX.Ai announces 21 CFR part 11 compliance of its flagship product iCore Cupertino, CA – July 7, 2019 In a major regulatory compliance achievement, iNDX.Ai has now tailored its SaaS-based iCore V4.0TM informatics platform to include compatibility of its documentation management suite with FDA’s Title 21 CFR Part 11 regulations. This means that iNDX.Ai’s clients…

iNDX.Ai Announces iCore Compliance with HIPAA

iNDX.Ai Announces iCore Compliance with HIPAA Sep 16, 2019 Compliance with HIPAA. Cupertino, CA – May 19, 2019, iNDX Technology, Inc. d/b/a iNDX.Ai, the leader for managing Immuno-Oncology clinical trials and translational research. iNDX.Ai helps scientists, researchers, and principal investigators find a cure for cancer by combining innovations in science with innovations in technology. We…

iNDX.Ai recognized as “Top 10 Bioinformatics Solution Providers – 2019” by CIO Magazine

iNDX Technology,Inc recognized as “Top 10 Bioinformatics Solution Providers – 2019” by CIO Applicant iNDX.Ai, a Bio-IT company based out of Silicon Valley focused at developing and providing innovative software products to guide translational research and enable better outcome for cancer cure has been recognized as “Top 10 Bioinformatics Solution Providers – 2019” by CIO…

iNDX.Ai Join End-pandemic National Data Consortium

DMN Newswire: Leading Life Sciences and IT Companies Join End-pandemic National Data Consortium Industries Answer Call-to-Action with Expertise and Resources to Mitigate Global Pandemic CAMPBELL, Calif.–(BUSINESS WIRE)–#covidcure–The EndPandemic National Data Consortium announced today that it has received commitments from six leading life sciences and information technology companies to join the Consortium, the formation of which…

iNDX.AI’s iCore Data Analytics Platform receives GXP compliant certification

iNDX.AI’s iCore Data Analytics Platform receives GXP compliant certification Cupertino, CA, February 12, 2021. iNDX.Ai is excited to announce our GXP Compliance Certification from NADH+, an FDA-approved certification agency that evaluated iNDX.Ai systems and found us in compliance with the highest GXP standards of quality. GXP compliance entails implementing a rigorous system of documentation and…

Collaborative case study for academic center

Collaborative case study for academic center Jaydeep Adhikari – Mar 23 The AAPM Annual Meeting 2021 brought together top experts and thought leaders in the fields of precision medicine, life science, biotech, medtech and pharma. The theme was “Accelerating Precision Medicine and Transforming Patient Health,” AAPM2021 serve as a leading forum for new medical breakthroughs…

Host‑dependent molecular factors mediating SARS‑CoV‑2 infection

Host‑dependent molecular factors mediating SARS‑CoV‑2 infection Gowhar Shafi·Shruti Desai·Krithika Srinivasan·Aarthi Ramesh·Rupesh Chaturvedi·Mohan Uttarwar Abstract   Corona virus disease 2019 (COVID-19), a recent viral pandemic that first began in December 2019, in Hunan wildlife market, Wuhan, China. The infection is caused by a corona virus, SARS-CoV-2, and clinically characterized by common symptoms including fever, dry cough,…